BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36884119)

  • 1. PLVAP protein expression correlated with microbial composition, clinicopathological features, and prognosis of patients with stomach adenocarcinoma.
    Wen Y; Wang Y; Huang Y; Liu Z; Hui C
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7139-7153. PubMed ID: 36884119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive bioinformatic analysis of mind bomb 1 gene in stomach adenocarcinoma.
    Wang D; Wang QH; Luo T; Jia W; Wang J
    World J Gastrointest Oncol; 2023 Jul; 15(7):1295-1310. PubMed ID: 37546549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic and antitumor roles of key genes of ferroptosis in liver hepatocellular cancer and stomach adenocarcinoma.
    Pei W; Jiang M; Liu H; Song J; Hu J
    Cancer Biomark; 2024; 39(4):335-347. PubMed ID: 38393890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 5. DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis.
    Lu Y; Yu J; Dong Q; Du Y; Liang Z
    Int J Gen Med; 2022; 15():6127-6143. PubMed ID: 35846794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer.
    Zhang X; Xu H; Zhang Y; Sun C; Li Z; Hu C; Zhao D; Guo C
    Front Oncol; 2022; 12():878546. PubMed ID: 35712475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
    Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
    Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solute carrier family 35 member A2 (SLC35A2) is a prognostic biomarker and correlated with immune infiltration in stomach adenocarcinoma.
    Huang Z; Yang H; Lao J; Deng W
    PLoS One; 2023; 18(7):e0287303. PubMed ID: 37467193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.
    Guo Y; Wang ZW; Su WH; Chen J; Wang YL
    Biomed Res Int; 2020; 2020():4145164. PubMed ID: 32685482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
    Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
    Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
    Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
    PeerJ; 2023; 11():e14645. PubMed ID: 36919165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value and therapeutic potential of NEK family in stomach adenocarcinoma.
    Zhou X; Nie H; Wang C; Yu X; Yang X; He X; Ou C
    J Cancer; 2024; 15(10):3154-3172. PubMed ID: 38706902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and role of nuclear receptor-interacting protein 1 (NRIP1) in stomach adenocarcinoma.
    Fang D; Lu G
    Ann Transl Med; 2020 Oct; 8(20):1293. PubMed ID: 33209873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
    Guo L; Liu D
    Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Expression of the Component 3a Receptor 1 (C3AR1) Gene in Stomach Adenocarcinomas Infers a Poor Prognosis and High Immune-Infiltration Levels.
    Yang H; Li L; Liu X; Zhao Y
    Med Sci Monit; 2021 Feb; 27():e927977. PubMed ID: 33539329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IRF7 is a Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma.
    Guo L; Fang T; Jiang Y; Liu D
    Int J Gen Med; 2021; 14():9887-9902. PubMed ID: 34938108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer.
    Zhang T; Lai S; Cai Y; Huang Z; Li Y; Chen S; Zhang Z; Ye Z; Lai X; Zhai E; Cai S; Chen J
    Front Cell Dev Biol; 2021; 9():719613. PubMed ID: 34869310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.